Evaluation of cardiovascular risk in stages of gout by a complex multimodal ultrasonography.

scientific article published on 30 August 2016

Evaluation of cardiovascular risk in stages of gout by a complex multimodal ultrasonography. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00296-016-3556-6
P698PubMed publication ID27577941

P2093author name stringZlatimir Kolarov
Todor Kundurzhiev
Mariana Ivanova
Atanas Kundurdjiev
Rada Gancheva
P2860cites workUric acid as an independent risk factor in the treatment of hypertensionQ77206589
Uric acid in chronic heart failure: a marker of chronic inflammationQ77788323
Uric acid and cardiovascular riskQ79689991
Relation of left ventricular hypertrophy with systemic inflammation and endothelial damage in resistant hypertensionQ80627954
Independent impact of gout on mortality and risk for coronary heart diseaseQ80795931
Serum uric acid is associated with microalbuminuria and subclinical atherosclerosis in men with type 2 diabetes mellitusQ81169690
Diversity of denizens of the atherosclerotic plaque: not all monocytes are created equalQ81508508
Prediction of cardiovascular morbidity and mortality: comparison of the internal carotid artery resistive index with the common carotid artery intima-media thicknessQ82388741
Cellular characterization of the gouty tophus: a quantitative analysisQ82777842
Elevated serum uric acid is an independent predictor for cardiovascular events in patients with severe coronary artery stenosis: subanalysis of the Japanese Coronary Artery Disease (JCAD) StudyQ83592216
The effects of gout on left atrial volume remodelling: a prospective echocardiographic studyQ87063317
Gout and the risk of acute myocardial infarctionQ28199792
Inflammation in atherosclerosisQ29547428
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratificationQ29547560
Gout and the risk for incident heart failure and systolic dysfunctionQ30505423
Hyperuricaemia, chronic kidney disease, and outcomes in heart failure: potential mechanistic insights from epidemiological dataQ33784030
Left ventricular hypertrophy: major risk factor in patients with hypertension: update and practical clinical applicationsQ34200319
Relationship between serum uric acid and internal carotid resistive index in hypertensive women: a cross-sectional studyQ34338766
Anemia as a risk factor for cardiovascular disease in The Atherosclerosis Risk in Communities (ARIC) studyQ34525035
Clinical application of C-reactive protein for cardiovascular disease detection and preventionQ35054464
Reduced creatinine clearance is associated with early development of subcutaneous tophi in people with goutQ35073601
Review. The resistive index in renal Doppler sonography: where do we stand?Q35088758
Serum uric acid level and its association with metabolic syndrome and carotid atherosclerosis in patients with type 2 diabetesQ35184941
Cardiovascular risk factors and comorbidities in patients with hyperuricemia and/or gout: a systematic review of the literatureQ35236580
Observations on Certain Pathological Conditions of the Blood and Urine in Gout, Rheumatism and Bright's DiseaseQ36182898
A clinician's guide to tissue Doppler imaging.Q36420143
Serum uric acid is associated with carotid plaques: the National Heart, Lung, and Blood Institute Family Heart Study.Q37317340
Ultrasound Doppler renal resistive index: a useful tool for the management of the hypertensive patientQ37403292
Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians.Q37602789
Inflammation, oxidative stress and lipids: the risk triad for atherosclerosis in goutQ37702650
Hypertension, its treatment, hyperuricaemia and goutQ38078199
Long-term cardiovascular mortality among middle-aged men with goutQ38390010
Inhibition of endothelial nitric oxide synthase by C-reactive protein: clinical relevanceQ43060919
Preliminary criteria for the classification of the acute arthritis of primary goutQ44734461
Impact of age on echocardiographic left ventricular mass in a healthy population (the Framingham Study).Q45410953
Uric acid and left ventricular hypertrophy in Japanese men.Q46118265
Tophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with gout.Q51203256
Comparison of carotid arterial resistive indices with intima-media thickness as sonographic markers of atherosclerosis.Q52930040
Renal Doppler resistance indices are associated with systemic atherosclerosis in kidney transplant recipients.Q53851170
2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).Q55057254
Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of EchocardioQ57217547
Carotid intima-media thickness by B-mode ultrasound as surrogate of coronary atherosclerosis: correlation with quantitative coronary angiography and coronary intravascular ultrasound findingsQ57398791
Serum Uric Acid and Risk for Cardiovascular Disease and Death: The Framingham Heart StudyQ57740599
Gout and coronary heart disease: the Framingham StudyQ68259225
Peak early diastolic mitral annulus velocity by tissue Doppler imaging adds independent and incremental prognostic valueQ73105448
Sex differences in uric acid and risk factors for coronary artery diseaseQ73989803
P433issue1
P304page(s)121-130
P577publication date2016-08-30
P1433published inRheumatology InternationalQ15763689
P1476titleEvaluation of cardiovascular risk in stages of gout by a complex multimodal ultrasonography.
P478volume37

Search more.